See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Imago BioSciences Earns $26.5M in Series

Imago BioSciences, a 2.5-year-old, San Francisco-based biotech company developing therapeutics for orphan diseases, has raised $26.5 million in Series A funding. http://goo.gl/DL5zZu

UP NEXT

More from